Cargando…
Targeting metastatic breast cancer with ANG1005, a novel peptide-paclitaxel conjugate that crosses the blood-brain-barrier (BBB)
We devoted this short interview piece with Dr Shou-Ching Tang at Augusta University to feature some promising results from a clinical phase II trial on a novel brain-penetrating peptide-paclitaxel-conjugate, ANG1005, in treating brain metastatic breast cancer. These results were presented by Dr. Tan...
Autores principales: | Li, Fei, Tang, Shou-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136589/ https://www.ncbi.nlm.nih.gov/pubmed/30258901 http://dx.doi.org/10.1016/j.gendis.2017.01.004 |
Ejemplares similares
-
Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell‐Penetrative MMP‐2‐Cleavable Peptide
por: Hua, Dan, et al.
Publicado: (2020) -
Branched BBB-shuttle peptides: chemoselective modification of proteins to enhance blood–brain barrier transport
por: Díaz-Perlas, Cristina, et al.
Publicado: (2018) -
Spontaneous penetration of gold nanoparticles through the blood brain barrier (BBB)
por: Sela, Hagit, et al.
Publicado: (2015) -
Setting-up an In Vitro Model of Rat Blood-brain Barrier (BBB): A Focus on BBB Impermeability and Receptor-mediated Transport
por: Molino, Yves, et al.
Publicado: (2014) -
Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1
por: Bertrand, Y, et al.
Publicado: (2011)